Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery

Clinical trial NCT02216266 · UNKNOWN

Trial details

NCT number: NCT02216266
Sponsor: PD Dr. Bertram Scheller
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Suspected Delirium After Elective or Emergency Heart Surgery CAM-ICU Diagnosed Delirium

Start date: 2014-04-01
Primary completion: 2018-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.